Pain reduction in fibromyalgia syndrome through pairing transcranial direct current stimulation and mindfulness meditation: A randomized, double-blinded, sham-controlled pilot clinical trial.
brain stimulation
fibromyalgia (FMS)
meditation
mindfulness
transcranial direct current stimulation (tDCS)
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2022
2022
Historique:
received:
20
04
2022
accepted:
23
08
2022
entrez:
31
10
2022
pubmed:
1
11
2022
medline:
1
11
2022
Statut:
epublish
Résumé
This double-blinded, randomized and sham-controlled pilot clinical trial aimed to investigate the preliminary clinical efficacy and feasibility of combining mindfulness meditation (MM) and transcranial direct current stimulation (tDCS) for pain and associated symptoms in patients with fibromyalgia syndrome (FMS). Included FMS patients (age: 33 to 70) were randomized to three different groups to receive either ten daily sessions of anodal tDCS over the left primary motor cortex paired with MM for 20 min (active + MM, n = 10), sham tDCS combined with MM (sham + MM, Participants in the active + MM group did not exhibit reduced pain intensity following the bimodal therapy compared to controls. Patients in active group demonstrated clinically meaningful and significantly higher quality of life following the therapeutic intervention than other groups. There was no significant difference among groups regarding pressure pain sensitivity, sleep parameters and psychological scales. The combined treatment was well tolerated among participants, with no serious adverse effects. This study was the first to pair these two effective non-pharmacological therapies for pain management in FMS. In the light of an underpowered sample size, repetitive anodal tDCS combined with MM did not improve pain or FMS-associated symptoms. However, patients in the active + MM group reported higher quality of life than the control groups. Studies with more participants and longer follow-ups are required to confirm our findings. [www.drks.de], identifier [DRKS00023490].
Sections du résumé
Background
UNASSIGNED
This double-blinded, randomized and sham-controlled pilot clinical trial aimed to investigate the preliminary clinical efficacy and feasibility of combining mindfulness meditation (MM) and transcranial direct current stimulation (tDCS) for pain and associated symptoms in patients with fibromyalgia syndrome (FMS).
Methods
UNASSIGNED
Included FMS patients (age: 33 to 70) were randomized to three different groups to receive either ten daily sessions of anodal tDCS over the left primary motor cortex paired with MM for 20 min (active + MM, n = 10), sham tDCS combined with MM (sham + MM,
Results
UNASSIGNED
Participants in the active + MM group did not exhibit reduced pain intensity following the bimodal therapy compared to controls. Patients in active group demonstrated clinically meaningful and significantly higher quality of life following the therapeutic intervention than other groups. There was no significant difference among groups regarding pressure pain sensitivity, sleep parameters and psychological scales. The combined treatment was well tolerated among participants, with no serious adverse effects.
Conclusion
UNASSIGNED
This study was the first to pair these two effective non-pharmacological therapies for pain management in FMS. In the light of an underpowered sample size, repetitive anodal tDCS combined with MM did not improve pain or FMS-associated symptoms. However, patients in the active + MM group reported higher quality of life than the control groups. Studies with more participants and longer follow-ups are required to confirm our findings.
Clinical trial registration
UNASSIGNED
[www.drks.de], identifier [DRKS00023490].
Identifiants
pubmed: 36314032
doi: 10.3389/fmed.2022.908133
pmc: PMC9596988
doi:
Types de publication
Journal Article
Langues
eng
Pagination
908133Informations de copyright
Copyright © 2022 Ramasawmy, Khalid, Petzke and Antal.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Brain Stimul. 2012 Oct;5(4):499-504
pubmed: 22405745
Conscious Cogn. 2010 Jun;19(2):597-605
pubmed: 20363650
Ann Rheum Dis. 2017 Feb;76(2):318-328
pubmed: 27377815
Schmerz. 2017 Jun;31(3):246-254
pubmed: 28493229
Neurology. 2005 Mar 8;64(5):872-5
pubmed: 15753425
Cogn Behav Ther. 2016;45(1):5-31
pubmed: 26818413
Front Aging Neurosci. 2014 Jun 06;6:115
pubmed: 24936185
PLoS One. 2017 Jun 30;12(6):e0180328
pubmed: 28665989
J Neuroimaging. 2020 Nov;30(6):808-814
pubmed: 32896933
Front Neurosci. 2019 May 08;13:467
pubmed: 31139047
Arthritis Rheum. 1995 Jun;38(6):727-35
pubmed: 7779114
Pain Med. 2017 Feb 1;18(2):316-321
pubmed: 28204781
Ann Behav Med. 2015 Jun;49(3):319-30
pubmed: 25425224
JAMA Intern Med. 2016 Mar;176(3):329-37
pubmed: 26903081
J Clin Neurosci. 2019 Dec;70:140-145
pubmed: 31421990
J Rehabil Med. 2017 Jan 19;49(1):2-9
pubmed: 27983739
Sci Rep. 2020 Sep 30;10(1):16108
pubmed: 32999375
Clin J Pain. 2013 Mar;29(3):224-32
pubmed: 23369928
Pain Physician. 2011 Mar-Apr;14(2):E217-45
pubmed: 21412381
Br J Health Psychol. 2017 Feb;22(1):186-206
pubmed: 27885763
Front Psychol. 2015 Mar 10;6:261
pubmed: 25806017
Clin Physiol Funct Imaging. 2013 Mar;33(2):83-91
pubmed: 23383685
Arthritis Rheum. 2003 Oct;48(10):2916-22
pubmed: 14558098
Open Rheumatol J. 2011;5:45-50
pubmed: 22046206
Int J Neuropsychopharmacol. 2011 Sep;14(8):1133-45
pubmed: 21320389
Pain Med. 2018 Apr 1;19(4):677-685
pubmed: 28460127
Pain. 2012 Dec;153(12):2359-2369
pubmed: 23017297
J Rheumatol. 2000 Aug;27(8):1984-8
pubmed: 10955342
J Rheumatol. 2009 Jun;36(6):1304-11
pubmed: 19369473
Front Hum Neurosci. 2016 Mar 10;10:68
pubmed: 27014012
Arthritis Rheum. 2002 May;46(5):1333-43
pubmed: 12115241
Qual Life Res. 2022 Aug;31(8):2519-2534
pubmed: 35229253
Arthritis Res Ther. 2007;9(4):216
pubmed: 17626613
Arthritis Rheum. 1990 Feb;33(2):160-72
pubmed: 2306288
Brain Res Bull. 2007 May 30;72(4-6):208-14
pubmed: 17452283
Arthritis Res Ther. 2016 Feb 03;18:40
pubmed: 26842987
Arthritis Rheumatol. 2015 Feb;67(2):576-81
pubmed: 25371383
Isr Med Assoc J. 2001 Oct;3(10):755-60
pubmed: 11692551
Brain Stimul. 2021 Jan-Feb;14(1):100-109
pubmed: 33197654
Ann Ist Super Sanita. 2016 Apr-Jun;52(2):184-9
pubmed: 27364392
Cephalalgia. 2010 Mar;30(3):285-95
pubmed: 19614706
Expert Rev Med Devices. 2020 Sep;17(9):879-898
pubmed: 32845195
J Pain. 2010 Mar;11(3):199-209
pubmed: 19853530
Brain Stimul. 2012 Jul;5(3):214-222
pubmed: 21782545
Brain Stimul. 2020 May - Jun;13(3):832-839
pubmed: 32289714
J Pain. 2013 Dec;14(12):1653-62
pubmed: 24290445
J Pain. 2020 Nov - Dec;21(11-12):1085-1100
pubmed: 31982685
Am Psychol. 2015 Oct;70(7):581-92
pubmed: 26436310
Brain Netw Modul. 2022 Apr-Jun;1(2):88-101
pubmed: 35845034
Brain Sci. 2021 Dec 31;12(1):
pubmed: 35053802
Pain. 2023 Feb 1;164(2):280-291
pubmed: 36095039
J Manipulative Physiol Ther. 1998 Jan;21(1):1-7
pubmed: 9467094
Arthritis Rheum. 2006 Dec;54(12):3988-98
pubmed: 17133529
J ECT. 2018 Sep;34(3):144-152
pubmed: 29877965
Arthritis Care Res (Hoboken). 2010 May;62(5):600-10
pubmed: 20461783
J Neurosci. 2015 Nov 18;35(46):15307-25
pubmed: 26586819
Sci Rep. 2016 Aug 18;6:31236
pubmed: 27535462
Brain Stimul. 2017 Sep - Oct;10(5):893-901
pubmed: 28684258
Front Hum Neurosci. 2020 Oct 28;14:568306
pubmed: 33192397
Gen Hosp Psychiatry. 1982 Apr;4(1):33-47
pubmed: 7042457
J Man Manip Ther. 2018 Feb;26(1):25-35
pubmed: 29456445
J Pain. 2013 Apr;14(4):371-83
pubmed: 23415877
Clin Neurophysiol. 2017 Jan;128(1):56-92
pubmed: 27866120
Int J Neuropsychopharmacol. 2021 Apr 21;24(4):256-313
pubmed: 32710772
J Rheumatol. 1995 May;22(5):944-52
pubmed: 8587087
J Pain Symptom Manage. 2010 May;39(5):890-903
pubmed: 20471549
Eur J Neurosci. 2019 Oct;50(8):3261-3268
pubmed: 30888090
Brain Stimul. 2009 Oct;2(4):215-28, 228.e1-3
pubmed: 20161507
Ann N Y Acad Sci. 2016 Jun;1373(1):114-27
pubmed: 27398643
Pain Pract. 2013 Feb;13(2):131-45
pubmed: 22631436
Exp Brain Res. 2005 Sep;166(1):23-30
pubmed: 15999258
Scand J Rheumatol Suppl. 2000;113:30-1
pubmed: 11028828
Neuropsychol Rehabil. 2011 Oct;21(5):602-17
pubmed: 21819181
Brain Stimul. 2012 Apr;5(2):155-62
pubmed: 22037128
J Neurosci. 2011 Apr 6;31(14):5540-8
pubmed: 21471390
J Rehabil Med. 2010 Sep;42(8):765-72
pubmed: 20809059
J Pain Manag. 2009;2(3):353-361
pubmed: 21170277
Comput Biol Med. 2015 Dec 1;67:126-35
pubmed: 26520483
J Altern Complement Med. 2010 Aug;16(8):867-73
pubmed: 20666590
Rev Bras Fisioter. 2010 Jul-Aug;14(4):284-9
pubmed: 20949228
Arthritis Rheumatol. 2015 Feb;67(2):568-75
pubmed: 25323744
Curr Rheumatol Rep. 2017 Sep;19(9):59
pubmed: 28752493
Princ Pract Clin Res. 2020 Jan-Apr;6(1):23-26
pubmed: 32766451
Clin J Pain. 2005 Jan-Feb;21(1):91-100
pubmed: 15599136
Pain. 2022 Jul 1;163(7):e850-e861
pubmed: 34561393
Arthritis Rheum. 1998 Sep;41(9):1564-70
pubmed: 9751088
Sci Rep. 2020 Mar 9;10(1):4323
pubmed: 32152347
Contemp Clin Trials. 2020 Nov;98:106159
pubmed: 32992020
Clin Exp Rheumatol. 2016 Mar-Apr;34(2 Suppl 96):S14-25
pubmed: 26812139
Schmerz. 2015 Dec;29(6):649-57
pubmed: 26205682
Front Neurol. 2020 Dec 11;11:568261
pubmed: 33362687